Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-18

Clinical Trial Update: Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden [NA]

View source ↗

Summary

Results from a completed trial evaluating a simplified isoniazid preventive therapy strategy to reduce the TB burden; results were posted on 2025-06-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

Sponsor: University of California, San Francisco | Conditions: Tuberculosis, HIV/AIDS | NA | Status: COMPLETED | Results posted: 2025-06-18